Financials in USD. Standardized financial statements.
A compact view of how Cano Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $2.74B | $1.61B | $831.58M | $361.38M |
| Revenue Growth? | +70.2% | +93.5% | +130.1% | 0.0% |
| Cost of Revenue? | $2.32B | $1.41B | $666.35M | $284.67M |
| Gross Profit? | $421.69M | $198.97M | $165.23M | $76.71M |
| Gross Margin? | +15.4% | +12.4% | +19.9% | +21.2% |
| Operating Expenses? | $513.08M | $301.57M | $122.46M | $65.97M |
| Operating Income? | -$89.67M | -$102.61M | $42.64M | $10.81M |
| EBITDA? | -$197.62M | -$48.62M | -$18.04M | $17.63M |
| Income Before Tax | -$426.23M | -$116.72M | -$70.41M | -$19.78M |
| Income Tax Expense | $2.16M | $14,000 | $651,000 | $9.91M |
| Net Income? | -$428.39M | -$116.74M | -$71.06M | -$29.69M |
| EPS? | $-87.60 | $-24.54 | $-42.75 | $-17.86 |
| Diluted EPS? | $-87.60 | $-24.54 | $-42.75 | $-17.86 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality